Guo-Liang Lu

Discovery of Novel Quinazoline-Based KDM1A Inhibitors as Dual Inducers of Ferroptosis and Apoptosis in Esophageal Cancer

In a KYSE510 xenograft model, oral administration of JH-1 significantly suppressed tumor growth without obvious toxicity and validate the quinazoline scaffold for epigenetic cancer therapy.